Back

CNBC traders pick AstraZeneca, Leidos and Expeditors in final trades

Verifying
  • Jim Lebenthal selected AstraZeneca, Stephen Weiss chose Leidos, and Joseph M. Terranova picked Expeditors.
  • Leidos reported $3.26 earnings per share and $4.558 billion in quarterly sales.
  • AstraZeneca shares rose 2.3% Monday, while Leidos gained 3.1% and Expeditors advanced 0.5%.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.